CIK 0001472012 · Non-accelerated filer
Immunome Inc.
Sign in to watch- Ticker
- IMNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770694340
- Phone
- 610-321-3700
- Business address
- 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $334,224
- in 1 filing, $334K under 10b5-1 plans
Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 56 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-15 | Higgins Jack Chief Scientific Officer | Option exercise · Stock option (right to buy) | −19,524 | 179,040 | ||
| 2024-08-09 | SIEGALL CLAY B President and CEO | Grant or award · Stock option (right to buy) | +800,000 | 800,000 | ||
| 2024-08-09 | Stoneman Sandra G. CHIEF LEGAL OFFICER & GC | Grant or award · Stock option (right to buy) | +210,000 | 210,000 | ||
| 2024-08-09 | Horn Kinney CHIEF BUSINESS OFFICER | Grant or award · Stock option (right to buy) | +130,000 | 130,000 | ||
| 2024-08-09 | Turner Bruce Chief Strategy Officer | Grant or award · Stock option (right to buy) | +110,000 | 110,000 | ||
| 2024-08-09 | Rosett Max EVP, Operations & CFO | Grant or award · Stock option (right to buy) | +190,000 | 190,000 | ||
| 2024-08-09 | Lechleider Robert Chief Medical Officer | Grant or award · Stock option (right to buy) | +200,000 | 200,000 | ||
| 2024-08-09 | Higgins Jack Chief Scientific Officer | Grant or award · Stock option (right to buy) | +190,000 | 190,000 | ||
| 2024-06-17 | Tsai Philip Chief Technology Officer | Grant or award · Stock option (right to buy) | +250,000 | 250,000 | ||
| 2024-06-13 | Boylan James P Director | Grant or award · Stock option (right to buy) | +11,333 | 11,333 | ||
| 2024-06-13 | SCHAFER CAROL Director | Grant or award · Stock option (right to buy) | +11,333 | 11,333 | ||
| 2024-06-13 | SWAIN SANDRA M Director | Grant or award · Stock option (right to buy) | +11,333 | 11,333 | ||
| 2024-06-13 | WAGENHEIM PHILIP Director | Grant or award · Stock option (right to buy) | +11,333 | 11,333 | ||
| 2024-06-13 | BIENAIME JEAN JACQUES Director | Grant or award · Stock option (right to buy) | +11,333 | 11,333 | ||
| 2024-06-13 | Barchas Isaac Director | Grant or award · Stock option (right to buy) | +11,333 | 11,333 | ||
| 2024-05-21 | BIENAIME JEAN JACQUES Director | Purchase | +2,000 | $13.57 | $27K | 9,615 |
| 2024-05-21 | SIEGALL CLAY B President and CEO | Purchase | +20,434 | $13.78 | $282K | 419,636 |
| 2024-05-20 | SIEGALL CLAY B President and CEO | Purchase | +79,566 | $13.91 | $1.1M | 399,202 |
| 2024-05-16 | Rosett Max EVP, Operations & CFO | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | ||
| 2024-04-25 | SWAIN SANDRA M Director | Grant or award · Stock option (right to buy) | +25,737 | 25,737 |
Page 7 of 8 · 159 trades